Advertisement

Reactions Weekly

, Volume 1780, Issue 1, pp 317–317 | Cite as

Thalidomide

Various toxicities following off label use: 3 case reports
Case report
  • 45 Downloads

Reference

  1. Kroiss M, et al. Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry. Experimental and Clinical Endocrinology and Diabetes 127: 578-584, No. 9, 2019. Available from: URL: http://doi.org/10.1055/a-0747-5571 - GermanyGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations